Anthony C. J. Fernando - 04 Feb 2024 Form 4 Insider Report for ASENSUS SURGICAL, INC.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Feb 2024, 19:00:04 UTC
Prior SEC filing
25 Apr 2023
Next SEC filing
23 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua Weingard as attorney-in-fact for Anthony Fernando

Key filing fact

Anthony C. J. Fernando filed Form 4 for ASENSUS SURGICAL, INC. on 06 Feb 2024.

Key facts

  • This page summarizes Anthony C. J. Fernando's Form 4 filing for ASENSUS SURGICAL, INC..
  • 11 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 06 Feb 2024, 19:00.

Change

  • Previous filing in this sequence was filed on 25 Apr 2023.
  • Current net transaction value: -$130,834.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASXC transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,042,772
Change %
+70%
Price
$0.000000
Shares after
2,531,165
Date
04 Feb 2024
Ownership
Direct
ASXC transaction

Common Stock

Tax liability

Transaction value
$130,834
Shares
-484,572
Change %
-19%
Price
$0.2700
Shares after
2,046,593
Date
04 Feb 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASXC transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+1,488,100
Change %
Price
$0.000000
Shares after
1,488,100
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,488,100
Exercise price
$0.2600
Footnotes
F2
ASXC transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+2,477,400
Change %
Price
$0.000000
Shares after
2,477,400
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,477,400
Exercise price
$0.000000
Footnotes
F3, F4
ASXC transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+1,238,700
Change %
Price
$0.000000
Shares after
1,238,700
Date
06 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,238,700
Exercise price
$0.000000
Footnotes
F5, F6
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-234,086
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
234,086
Exercise price
$0.000000
Footnotes
F5, F7
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-234,086
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
234,086
Exercise price
$0.000000
Footnotes
F3, F8
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-162,300
Change %
-50%
Price
$0.000000
Shares after
162,300
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,300
Exercise price
$0.000000
Footnotes
F5, F9
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-162,300
Change %
-50%
Price
$0.000000
Shares after
162,300
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162,300
Exercise price
$0.000000
Footnotes
F3, F10
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-125,000
Change %
-33%
Price
$0.000000
Shares after
250,000
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,000
Exercise price
$0.000000
Footnotes
F5, F11
ASXC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-125,000
Change %
-33%
Price
$0.000000
Shares after
250,000
Date
04 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,000
Exercise price
$0.000000
Footnotes
F3, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.

Footnote F2

Vests one-third annually on each of the first three anniversaries of the date of grant, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").

Footnote F3

Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.

Footnote F4

PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are achieved. The Reporting Person must continue to provide services to the Company during the vesting period.

Footnote F5

Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.

Footnote F6

Forfeiture restrictions will lapse on the RSUs in three installments on each of February 4, 2025, 2026 and 2027, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Reporting Person's Employment Agreement.

Footnote F7

Lapse of forfeiture restrictions on the third one-third of an award of RSUs from a grant made on February 8, 2021.

Footnote F8

Lapse of forfeiture restrictions on third one-third of a PRSU award granted on February 8, 2021 upon the achievement of time and performance goals.

Footnote F9

Lapse of forfeiture restrictions on the second one-third of an award of RSUs from a grant made on February 4, 2022. The remaining RSUs will vest on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period, and subject to acceleration as set forth in the Plan and the Reporting Person's Employment Agreement.

Footnote F10

Lapse of forfeiture restrictions on the second one-third of a PRSU Award from a grant made on February 4, 2022. The remaining PRSUs will vest on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period, and subject to acceleration as set forth in the Plan and the Reporting Person's Employment Agreement.

Footnote F11

Lapse of forfeiture restrictions on first one-third of a time-based RSU award granted on February 3, 2023. The remaining RSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Plan and the Reporting Person's Employment Agreement.

Footnote F12

Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Plan and the Reporting Person's Employment Agreement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .